| Literature DB >> 24511386 |
E Sierecki1, N Giles1, M Polinkovsky1, M Moustaqil1, K Alexandrov1, Y Gambin1.
Abstract
Protein-protein interactions are highly desirable targets in drug discovery, yet only a fraction of drugs act as binding inhibitors. Here, we review the different technologies used to find and validate protein-protein interactions. We then discuss how the novel combination of cell-free protein expression, AlphaScreen and single-molecule fluorescence spectroscopy can be used to rapidly map protein interaction networks, determine the architecture of protein complexes, and find new targets for drug discovery.Keywords: AlphaScreen; drug discovery; in vitro protein expression; protein–protein interactions; single-molecule fluorescence
Year: 2013 PMID: 24511386 PMCID: PMC3915825 DOI: 10.1098/rsfs.2013.0018
Source DB: PubMed Journal: Interface Focus ISSN: 2042-8898 Impact factor: 3.906